Search Within

Vincent Miller

Formats
  1. Journal Article (152)
  2. Meeting Abstract (114)
  3. Book Section (2)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (207)
  2. Solid Tumor Oncology Division (197)
  3. Thoracic Oncology (189)
  4. Department of Pathology and Laboratory Medicine (71)
  5. GSK Faculty (67)
  6. Human Oncology and Pathogenesis Program (64)

More Groups

People
  1. Mark Kris (172)
  2. Gregory Riely (79)
  3. William Pao (65)
  4. Marc Ladanyi (59)
  5. Christopher Azzoli (46)
  6. Maureen Zakowski (46)

More People

Years
  1. 2019 (1)
  2. 2017 (2)
  3. 2016 (1)
  4. 2015 (3)
  5. 2014 (5)
  6. 2013 (4)

More Years

Publications
  1. Journal of Clinical Oncology (80)
  2. Clinical Cancer Research (39)
  3. Journal of Thoracic Oncology (24)
  4. Seminars in Oncology (13)
  5. Cancer (10)
  6. Cancer Chemotherapy and Pharmacology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (80)
  2. American Association for Cancer Research (57)
  3. Elsevier Inc. (38)
  4. Elsevier Science, Inc. (11)
  5. Springer (10)
  6. Wiley Blackwell (10)

More Publishers

Results (270)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bronchioloalveolar carcinoma of the lung
    Book Section

    Riely, G. J.; Miller, V. A.
    In Raghavan, D.; Brecher, M. L.; Johnson, D. H.; Meropol, N. J.; Moots, P. L.; Rose, P. G.; Mayer, I. A. (Eds.) Textbook of Uncommon Cancer. 3rd ed (2006)

    Fulltext@MSK | Save
  • Acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
    Meeting Abstract

    Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Phase I/II study of ABI-007 as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Rizvi, N. A.; Azzoli, C.; Miller, V.; Ng, K.; Fiore, J.; Chia, G.; Brower, M.; Heelan, R.; Hawkins, M.; Kris, M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Prospective FDG-PET and CT assessment of discontinuation of erlotinib (E) or gefitinib (G) in patients with EGFR TKI sensitive non-small cell lung cancer (NSCLC) who subsequently progress radiographically on E or G ("acquired resistance") followed by re-initiation of E or G and the subsequent addition of everolimus (RAD001)
    Meeting Abstract

    Riely, G. J.; Kris, M. G.; Schwartz, L. H.; Akhurst, T.; Zhao, B.; Milton, D. T.; Moore, E.; Tyson, L.; Pao, W.; Miller, V. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Molecular analysis of NSCLC patients with acquired resistance to gefitinib or erlotinib
    Meeting Abstract

    Pao, W.; Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • EGFR mutation and copy number, EGFR protein expression and KRAS mutation as predictors of outcome with erlotinib in bronchioloalveolar cell carcinoma (BAC): Results of a prospective phase II trial
    Meeting Abstract

    Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Ladanyi, M.; Tsao, A. S.; Sandler, A.; Herbst, R.; Kris, M. G.; Johnson, D. H.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • EGFR mutation analysis in 334 consecutive non-small cell lung cancers: Evidence for frequent amplification of the mutant EGFR allele and survival correlations of mutation type
    Meeting Abstract

    Li, A. R.; Riely, G. J.; Zakowski, M. F.; Pao, W.; Ma, Y. Y .; Miller, V. A.; Kris, M. G.; Ladanyi, M.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • EGFR mutation analysis in 334 consecutive non-small cell lung cancers: Evidence for frequent amplification of the mutant EGFR allele and survival correlations of mutation type
    Meeting Abstract

    Li, A. R.; Riely, G. J.; Zakowski, M. F.; Pao, W.; Ma, Y. Y .; Miller, V. A.; Kris, M. G.; Ladanyi, M.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save
  • Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas
    Journal Article

    Pham, D. K.; Kris, M. G.; Riely, G. J.; Sarkaria, I. S.; McDonough, T.; Chuai, S. K.; Venkatraman, E. S.; Miller, V. A.; Ladanyi, M.; Pao, W.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • BAC Symposium: New York, November 4-6, 2004 - Introduction
    Journal Article

    Hirsch, F. R.; Johnson, D. H.; Miller, V. A.
    Journal of Thoracic Oncology (2006)

    Fulltext@MSK | Save